Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  2. TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

    Journal of the European Academy of Dermatology and Venereology

2022

  1. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  2. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

2021

  1. Definition of prognostic subgroups in the T3 stage of the eighth edition of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Tentative T3 stage subclassification

    Journal of the American Academy of Dermatology, Vol. 85, Núm. 5, pp. 1168-1177

  2. Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma

    Cancers, Vol. 13, Núm. 20

  3. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma

    Journal of the American Academy of Dermatology, Vol. 84, Núm. 4, pp. 938-945

2020

  1. Stromal SNAI2 is required for ERBB2 breast cancer progression

    Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230

2019

  1. MicroRNA dysregulation in cutaneous squamous cell carcinoma

    International Journal of Molecular Sciences, Vol. 20, Núm. 9